Neurology. 2013 Feb 26;80(9):869-70. doi: 10.1212/01.wnl.0000427909.23467.39.
Peer Carsten Tfelt-Hansen, Glostrup, Denmark: According to the recent American Academy of Neurology (AAN) guideline update, a drug can be recommended as possibly effective for migraine prevention if it had demonstrated efficacy in one Class II study.(1) Eight drugs are recommended as possibly effective,(1) and there are several drugs for which I would question the evidence. Due to space limitations, I have chosen just one example.
丹麦哥本哈根Peer Carsten Tfelt-Hansen:根据最近的美国神经病学学会(AAN)指南更新,如果一种药物在一项 II 类研究中显示出疗效,就可以推荐其作为预防偏头痛的可能有效药物。(1) 推荐了八种可能有效的药物,(1) 对于其中几种药物,我对其证据存在疑问。由于篇幅限制,我只选择了一个例子。